Similar articles for PMID: 29205470

Year	Number of Results
2015	3
2016	5
2017	31
2018	85
2019	78
2020	32
2021	10
2022	2
2023	5
2024	0

1

New onset of psoriasis during nivolumab treatment for lung cancer.

Chujo S, Asahina A, Itoh Y, Kobayashi K, Sueki H, Ishiji T, Umezawa Y, Nakagawa H. Chujo S, et al. J Dermatol. 2018 Mar;45(3):e55-e56. doi: 10.1111/1346-8138.14167. Epub 2017 Dec 4. J Dermatol. 2018. PMID: 29205470 No abstract available.

2

Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient.

Karakas Y, Yuce D, Kılıckap S. Karakas Y, et al. Oncol Res Treat. 2017;40(10):621-622. doi: 10.1159/000477968. Epub 2017 Sep 19. Oncol Res Treat. 2017. PMID: 28950270 Free article. No abstract available.

3

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety.

Hida T. Hida T. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618801167. doi: 10.1177/1753466618801167. Ther Adv Respir Dis. 2018. PMID: 30249170 Free PMC article. Review.

4

Nivolumab-induced asthma in a patient with non-small-cell lung cancer.

Maeno K, Fukuda S, Oguri T, Niimi A. Maeno K, et al. Ann Oncol. 2017 Nov 1;28(11):2891. doi: 10.1093/annonc/mdx455. Ann Oncol. 2017. PMID: 28945837 Free article. No abstract available.

5

Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment.

Paolini L, Poli C, Blanchard S, Urban T, Croué A, Rousselet MC, Le Roux S, Labarrière N, Jeannin P, Hureaux J. Paolini L, et al. J Immunother Cancer. 2018 Jun 13;6(1):52. doi: 10.1186/s40425-018-0372-4. J Immunother Cancer. 2018. PMID: 29898781 Free PMC article.

6

Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.

Cho M, Nonomura Y, Kaku Y, Nakabo S, Endo Y, Otsuka A, Kabashima K. Cho M, et al. J Dermatol. 2019 Jan;46(1):e43-e44. doi: 10.1111/1346-8138.14492. Epub 2018 Jun 4. J Dermatol. 2019. PMID: 29863795 No abstract available.

7

HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors.

Yoneshima Y, Kato K, Minami H, Ikeda M, Watanabe H, Yoshimoto G, Miyamoto T, Akashi K, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Cancer Sci. 2020 Sep;111(9):3395-3396. doi: 10.1111/cas.14536. Epub 2020 Jul 18. Cancer Sci. 2020. PMID: 32557883 Free PMC article. No abstract available.

8

Immune-related intestinal pseudo-obstruction associated with nivolumab treatment in a lung cancer patient.

Fragulidis G, Pantiora E, Michalaki V, Kontis E, Primetis E, Vezakis A, Polydorou A. Fragulidis G, et al. J Oncol Pharm Pract. 2019 Mar;25(2):487-491. doi: 10.1177/1078155217738325. Epub 2017 Oct 25. J Oncol Pharm Pract. 2019. PMID: 29067858

9

Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding.

Dall'Olio FG, Sperandi F, Rihawi K, Gargiulo M, Melotti B, Brocchi S, Gelsomino F, Ardizzoni A. Dall'Olio FG, et al. J Thorac Oncol. 2018 Dec;13(12):e247-e248. doi: 10.1016/j.jtho.2018.07.013. J Thorac Oncol. 2018. PMID: 30467045 Free article. No abstract available.

10

Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.

Tanaka M, Hoashi T, Ichiyama S, Noro R, Seike M, Kubota K, Gemma A, Funasaka Y, Saeki H. Tanaka M, et al. Australas J Dermatol. 2019 Feb;60(1):e67-e68. doi: 10.1111/ajd.12868. Epub 2018 Jun 13. Australas J Dermatol. 2019. PMID: 29896926 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

206 results

Results by year